Clinical Research Directory
Browse clinical research sites, groups, and studies.
MAX - SHOCK Clinical Trial
Sponsor: Ottawa Heart Institute Research Corporation
Summary
Can Electrical Cardioversion (ECV) for AF be improved. It is the preferred method to restore sinus rhythm in patients with AF in whom a rhythm-control strategy is pursued. Hypothesis: ECV success rates will be greater with a biphasic defibrillator with maximum energy of 360J (® Physio-Control) compared to a biphasic defibrillator with maximum energy of 200J (® Zoll)
Official title: Comparison of Maximum Energy Shocks From Two Defibrillator Vendors MAX - SHOCK- A Randomized Controlled Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
376
Start Date
2025-03-31
Completion Date
2027-09-01
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
biphasic defibrillator with maximum energy of 200J (® Zoll)
Cardioversion
biphasic defibrillator with maximum energy of 360J (® Physio-Control)
Cardioversion
Locations (1)
University of Ottawa Heart Institute
Ottawa, Ontario, Canada